Mortality among HIV/AIDS patients with/without Mycobacterium tuberculosis infection in southern region of Thailand
Author(s) -
Chaimay B,
Woradet S,
Chantuta S,
Phuntara S,
Suwanna K
Publication year - 2012
Publication title -
journal of the international aids society
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.724
H-Index - 62
ISSN - 1758-2652
DOI - 10.7448/ias.15.6.18412
Subject(s) - medicine , tuberculosis , mycobacterium tuberculosis , opportunistic infection , prospective cohort study , human immunodeficiency virus (hiv) , coinfection , cohort , mortality rate , aids related opportunistic infections , cohort study , immunology , sida , viral disease , pathology
Object The purpose of this study was to gain knowledge of tuberculosis infection in HIV/AIDS‐infected patients, the purpose of this study was to investigate an association between tuberculosis infection and mortality in HIV/AIDS‐infected patients. Methods A prospective, hospital‐based cohort study was conducted in HIV/AIDS patients registered in hospitals between January 1993 and April 2010. In total, 52,459 patients with HIV/AIDS infection were routinely observed and followed up, covering 14 provinces in southern region of Thailand. Results The main results found that one‐third of the HIV/AIDS patients were infected with Mycobacterium tuberculosis (27.94%) during the follow‐up period. However, the risk of Mycobacterium tuberculosis infection was not statistically significant in terms of association with mortality among HIV/AIDS patients (HR: 1.01; 95% CI: 0.96 to 1.05). In contrary, HIV/AIDS patients with pulmonary tuberculosis were more likely to have a longer life by about 19% (HR: 0.81, 95% CI: 0.73 to 0.91). As well, HIV/AIDS patients with extrapulmonary tuberculosis were more likely to have a longer life by about 31% (HR: 0.69; 95% CI: 0.57 to 0.83). Conclusion In conclusion, tuberculosis infection was associated with mortality among HIV/AIDS patients. Early treatment of tuberculosis is needed for HIV/AIDS patients, in order to decrease morbidity and mortality among HIV/AIDS patients with tuberculosis.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom